| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.3M | — | -22.3% |
| Cost of Revenue | $2.5M | — | -30.7% |
| Gross Profit | $2.8M | — | -13.1% |
| R&D Expense | $992K | — | -9.4% |
| SG&A Expense | $3.3M | — | -5.2% |
| Operating Income | -$3.9M | — | +27.0% |
| Pre-tax Income | -$6.6M | — | -12.5% |
| Income Tax | $2K | — | +0.0% |
| Net Income | -$6.6M | — | -12.4% |
| EPS (Basic) | -$4.70 | — | -1707.7% |
| EPS (Diluted) | -$4.70 | — | -1707.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.6M | +80.3% | -32.4% |
| Inventory | $2.0M | -15.4% | +2.5% |
| Current Assets | $9.4M | +45.5% | -3.6% |
| Total Assets | $10.5M | +38.1% | +6.4% |
| Current Liabilities | $13.1M | -24.3% | -34.3% |
| Long-term Debt | $20.3M | +14.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | +34.9% |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $4.9M | — | +399.5% |
| +166.4% |
| Total Liabilities | $35.9M | +19.1% | +21.7% |
| Stockholders' Equity | -$25.4M | -12.7% | -29.3% |